Every morning – shortly after checking my phone and shortly before brushing my teeth – I pull down my lower eyelids in turn ...

Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...

The closing of the merger is expected to occur as soon as practicable, subject to the satisfaction or waiver of the remaining customary closing conditions. Following the closing of the merger, the ...

UAB ophthalmology professor awarded prestigious award for vision research in diabetic retinopathy and macular degeneration ...

High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...

We don't pay much attention to our eyes until there's a problem. Most of us wait until daily life or reading becomes blurry, "floaters" invade our vision or glare from the headlights of oncoming cars ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Needham initiated coverage on Ocular Therapeutix Inc (NASDAQ:OCUL), noting the company’s lead asset, Axpaxli, an investigational axitinib-based intravitreal implant for wet age-related macular ...

Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

People who worked on local programs for emergency food, flood mapping and housing assistance have lost their jobs in New York ...